Journal of Cancer Genetics And Biomarkers

Aims And Scope

 

The Journal of Cancer Genetics and Biomarkers aims to provide a platform for the dissemination of high-quality research in the field of cancer genetics and biomarkers. The journal publishes original research articles, reviews, and perspectives that focus on the genetic and molecular basis of cancer, and the identification and validation of biomarkers for early detection, diagnosis, prognosis, and treatment of cancer.

 

The journal's scope includes, but is not limited to, the following areas:

 

Cancer genetics: Studies that investigate the genetic and epigenetic changes that contribute to the development and progression of cancer.

 

Cancer genomics: Research that utilizes high-throughput sequencing and other genomic technologies to identify and understand the genetic changes that underlie cancer.

 

Cancer epigenetics: Studies that investigate the role of epigenetic changes, such as DNA methylation and histone modification, in the development and progression of cancer.

 

Cancer biomarkers: Research that aims to identify and validate biomarkers for early detection, diagnosis, prognosis, and treatment of cancer.

 

Cancer personalized medicine: Studies that aim to use genetic and molecular information to develop personalized treatment strategies for cancer patients.

 

Cancer prevention and therapy: Research that investigates the genetic and molecular basis of cancer and develops new treatments and therapies for cancer.

 

Cancer epidemiology and public health: Studies that investigate the genetic, environmental, and lifestyle factors that contribute to the development and progression of cancer, and the impact of cancer on public health.

 

The Journal of Cancer Genetics and Biomarkers welcomes submissions from researchers working in the field of cancer genetics and biomarkers, and aims to be a leading forum for the dissemination of new findings and ideas in this rapidly-evolving field.

 

JCGB encourages the submission of manuscripts from all areas of cancer research, including basic and clinical research, laboratory studies, and animal models. The journal particularly welcomes submissions focusing on identifying and delineating biomarkers associated with cancer risk and prognosis, assessing and validating cancer biomarkers, and understanding the underlying biology, genomics and epigenetics of cancer.

Journal of Cancer Genetics And Biomarkers also accepts special issue proposals from the existing editorial board members and also from guest editors in the respective area. A few topics to organize special issues are listed below.

• Precision Medicine in Cancer Treatment
• Genomic Instability and Cancer Risk
• Cancer Immunogenomics
• Liquid Biopsies in Cancer Genomics
• Hereditary Cancer Syndromes
• Epigenetics and Cancer
• Genomic Heterogeneity in Tumors
• Integration of Multi-Omics Data in Cancer Genomics
• Cancer Genomics and Drug Resistance
• Big Data Analytics in Cancer Genomics
• Environmental Factors and Cancer Genetics
• Liquid Biopsies for Cancer Detection
• Novel Biomarkers for Early Cancer Diagnosis
• Biomarkers in Immunotherapy Response
• Exosomal Biomarkers
• Biomarkers for Cancer Prognosis
• Metabolic Biomarkers in Cancer
• Genomic and Transcriptomic Biomarkers
• Circulating Biomarkers in Minimal Residual Disease
• Multi-Omics Integration for Biomarker Discovery
• Biomarkers in Pediatric Cancers
• Artificial Intelligence in Biomarker Discovery
• Biomarkers for Personalized Cancer Therapy
• Microbiome and Cancer Biomarkers

The journal also seeks to promote interdisciplinary collaborations between researchers, clinicians, and healthcare professionals. JCGB encourages the submission of manuscripts that contribute to the advancement of cancer genetics and biomarker research and will be of great benefit to the cancer research community and to the wider biomedical science community.

 

Contributions from the following research areas are invited but not limited to the following branches :

• Acute lymphoblastic anemia
• Acute lymphocytic leukemia
• Biomarker Analysis
• Biomarker Assays
• Biomarker Assays in Cancer
• Biomarker Assessment
• Biomarker Correlation
• Biomarker Correlation in Oncology
• Biomarker Development
• Biomarker Discovery
• Biomarker Discovery in Oncology
• Biomarker Expression
• Biomarker Expression in Tumors
• Biomarker Identification
• Biomarker Kinetics
• Biomarker Kinetics in Cancer
• Biomarker Panels
• Biomarker Panels in Oncology
• Biomarker Patterns
• Biomarker Profiling
• Biomarker Profiling in Oncology
• Biomarker Response
• Biomarker Response in Oncology
• Biomarker Screening
• Biomarker Signatures
• Biomarker Signatures in Cancer
• Biomarker Testing
• Biomarker Validation
• Biomarker Validation in Oncology
• Biomarkers
• Biomarkers in cancer
• Biomolecular Markers
• Cancer
• Cancer bioinformatics
• Cancer biomarker discovery
• Cancer Biomarkers
• Cancer clinical trials
• Cancer diagnosis
• Cancer drug resistance genetics
• Cancer Epigenetics
• Cancer Evolution
• Cancer gene expression
• Cancer gene panels
• Cancer gene therapy
• Cancer Genetic Counseling
• Cancer Genetics
• Cancer genetics and prevention
• Cancer genome editing
• Cancer Genome Sequencing
• Cancer Genomic Biomarkers
• Cancer Genomic Profiling
• Cancer Genomics
• Cancer Genomics Databases
• Cancer genotyping
• Cancer immunogenetics
• Cancer immunotherapy
• Cancer metabolomics
• Cancer omics
• Cancer pharmacogenetics
• Cancer pharmacogenomics
• Cancer predisposition syndromes
• Cancer prognosis
• Cancer proteomics
• Cancer risk assessment
• Cancer screening
• Cancer Stem Cells
• Cancer Susceptibility Genes
• Cancer susceptibility testing
• Circulating Biomarkers
• Circulating Biomarkers in Oncology
• Circulating tumor DNA
• Circulating Tumor DNA (ctDNA) Biomarkers
• Colorectal Cancer
• Comparative Genomic Hybridization (CGH)
• Copy Number Alterations in Cancer
• CTC
• Cytotoxic T-lymphocytes
• Diagnosis
• Diagnostic Biomarkers
• Diagnostic Biomarkers in Cancer
• DNA Biomarkers
• DNA Biomarkers in Oncology
• DNA mutations in cancer
• DNA Repair Genes
• DNA Repair Genes in Cancer
• Driver Mutations
• Driver Mutations in Cancer
• Epigenetic Biomarkers
• Epigenetic biomarkers in cancer
• Epigenetic Biomarkers in Oncology
• Epigenetics in Cancer
• Exosomal Biomarkers in Cancer
• Familial cancer
• Functional Genomics in Cancer
• Functional Genomics in Cancer Therapy
• Functional Genomics in Oncology
• Gene expression profiling in cancer
• Gene fusions in cancer
• Gene Therapy
• Genetic Biomarkers
• Genetic Biomarkers in Oncology
• Genetic counseling for cancer
• Genetic Heterogeneity in Cancer
• Genetic Markers in Cancer
• Genetic Markers in Oncology
• Genetic Predisposition to Cancer
• Genetic testing for cancer
• Genetic Testing in Oncology
• Genetic Variants in Cancer
• Genomic Alterations in Cancer
• Genomic Instability
• Genomic Instability in Cancer
• Genomic medicine in cancer
• Genomic Medicine in Oncology
• Genomic Profiling of Cancer
• Germline Mutations
• Germline Mutations in Cancer
• Hereditary Cancer Syndromes
• Hereditary Cancer Testing
• Imaging Biomarkers
• Imaging Biomarkers in Oncology
• Immune checkpoint inhibitors in cancer
• Immunogenomics in Cancer
• Immunohistochemical Biomarkers
• Immunohistochemical Biomarkers in Cancer
• Immunotherapy
• JCGB
• Liquid Biopsy Biomarkers
• Liquid biopsy in cancer
• Lymphoma
• Metabolic Biomarkers
• Metabolic Biomarkers in Cancer
• Molecular Biomarkers
• Molecular Biomarkers in Oncology
• Molecular Diagnostics in Cancer
• Molecular Genetics of Cancer
• Molecular markers in cancer
• Molecular Oncology
• Molecular Pathology in Oncology
• Mutation
• Mutational Signatures
• Neuroblastoma
• Next-generation sequencing in cancer
• Non-coding RNA in cancer
• Oncogenes
• Oncogenetics
• Oncogenic Mutations
• Oncogenomic Pathways
• Oncology Biomarkers
• Oncology Genetics
• Osteosarcoma
• Palliative care
• Pediatric cancer genetics
• Personalized cancer treatment
• Pharmacogenomics in Cancer
• Pharmacogenomics in Oncology
• Precision medicine
• Precision Oncology
• Predictive Biomarkers
• Predictive Biomarkers in Cancer
• Prognosis
• Prognostic Biomarkers
• Prognostic Biomarkers in Oncology
• Protein Biomarkers
• Protein Biomarkers in Cancer
• Relapsed Cancer
• RNA Biomarkers
• RNA Biomarkers in Cancer
• Serum Biomarkers
• Serum Biomarkers in Cancer
• Single Nucleotide Polymorphisms (SNPs) in Cancer
• Somatic Mutations
• Somatic Mutations in Cancer
• Stem Cells
• Targeted Therapies in Cancer Genetics
• Targeted therapy in cancer
• Translational Oncogenomics
• Tumor
• Tumor Genetics
• Tumor heterogeneity
• Tumor Markers
• Tumor Microenvironment Genetics
• Tumor Suppressor Genes